![Frank Torti](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Torti
Président chez
IMMUNOVANT, INC.
Fortune : 440 M $ au 31/05/2026
Profil
Frank M.
Torti is currently Chairman at Axovant Sciences, Inc., Dermavant Sciences, Inc., Genevant Sciences Corp., Aruvant Sciences, Inc., Immunovant Sciences Ltd., and Dermavant Sciences Ltd. He serves as Chairman-Vant at Roivant Sciences, Inc., Executive Chairman at Immunovant, Inc., Director at Point32health Services, Inc., and Director at Myovant Sciences, Inc. Former roles include Chairman & Chief Executive Officer at Telavant, Inc. (2022–2024), Chairman at Sio Gene Therapies, Inc. (2018–2023), Chairman at Immunovant, Inc., Vice Chairman at Respivant Sciences, Inc., Chairman at Arbutus Biopharma Corp.
(2018–2025), Director at NeoTract, Inc., Earlens Corp., Annexon, Inc., Galera Therapeutics, Inc., Avalo Therapeutics, Inc., Tarveda Therapeutics, Inc., Eargo, Inc., OrphoMed, Inc., Novast Pharmaceuticals Ltd., Xoc Pharmaceuticals, Inc., Altavant Sciences, Inc., Wasatch Advisors LP, Revolution Health Group LLC, and Urovant Sciences Ltd. and Urovant Sciences, Inc. (2018–2019).
He was Senior Associate at NEA Management Co. LLC (2007–2018) and Partner at New Enterprise Associates LLC (2007–2018).
Education includes undergraduate studies at The University of North Carolina at Chapel Hill, an MBA from Harvard Business School, and a doctorate from UNC School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Roivant Sciences Ltd.
 Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases 1,88% | 30/06/2026 | 13 536 202 ( 1,88% ) | 406 M $ | 31/05/2026 |
IMMUNOVANT INC 0,5% | 07/04/2026 | 1 009 228 ( 0,5% ) | 34 M $ | 31/05/2026 |
Postes actifs de Frank Torti
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOVANT, INC. | Président | 18/12/2019 |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning | Président | - |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Président | - |
Point32health Services, Inc.
 Point32health Services, Inc. Life/Health InsuranceFinance Provides healthcare coverage services | Directeur/Membre du Conseil | 01/01/2016 |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Président | 01/06/2019 |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Directeur/Membre du Conseil | - |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Président | - |
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapeutics in immuno-dermatology | Président | 01/08/2018 |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Operates as a a biotechnology company focused on dermatology | Président | 05/09/2018 |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Frank Torti
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Frank Torti
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
36
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 36 |
|---|---|
Wasatch Advisors LP
 Wasatch Advisors LP Investment ManagersFinance Wasatch develops a fundamental, bottom-up research method that focuses on the long-term growth potential of companies and finding market inefficiencies. The firm initially focused on investing in the stocks of companies with small market capitalizations, and over time has organically evolved into additional asset classes. They select investments for clients based solely on investment considerations, including whether the investments are suitable for the client and consistent with the client’s investment objectives and guidelines. | Finance |
NeoTract, Inc.
 NeoTract, Inc. BiotechnologyHealth Technology Develops surgical devices for urological and gynecological disorders | Health Technology |
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Earlens Corp.
 Earlens Corp. Medical SpecialtiesHealth Technology Develops medical devices including hearing aids | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
Galera Therapeutics, Inc.
 Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Finance |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revolution Health Group LLC
 Revolution Health Group LLC Internet Software/ServicesTechnology Services Provides online consumer-directed healthcare services | Technology Services |
Point32health Services, Inc.
Point32health Services, Inc. Life/Health InsuranceFinance Provides healthcare coverage services | Finance |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UNC School of Medicine
 UNC School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Eargo, Inc.
 Eargo, Inc. Medical SpecialtiesHealth Technology Designs and manufactures hearing aids | Health Technology |
OrphoMed, Inc.
 OrphoMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Health Technology |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
Novast Pharmaceuticals Ltd.
 Novast Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical drugs | Health Technology |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Operates as a a biotechnology company focused on dermatology | Health Technology |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Xoc Pharmaceuticals, Inc.
 Xoc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel oral therapies for migraine prevention and dopamine agonism parkinson’s disease management | Commercial Services |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies for urologic conditions | Health Technology |
Urovant Sciences Ltd.
 Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for urologic conditions | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
New Enterprise Associates LLC
 New Enterprise Associates LLC Investment ManagersFinance Operates as a venture capital firm | Finance |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops life-saving medicines for patients with rare respiratory diseases | Health Technology |
Respivant Sciences, Inc.
 Respivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies for patients with respiratory diseases | Health Technology |
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapeutics in immuno-dermatology | Health Technology |
Immunovant, Inc. /Old/
 Immunovant, Inc. /Old/ BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Aruvant Sciences, Inc.
Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning | Health Technology |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Telavant, Inc.
 Telavant, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for inflammatory and fibrotic diseases | Health Technology |
Choisissez Zonebourse 
